Cargando…
Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618320/ http://dx.doi.org/10.1186/1479-5876-11-82 |
| _version_ | 1782265400023580672 |
|---|---|
| author | Hamilton, Erika Blackwell, Kimberly Hobeika, Amy C Clay, Timothy M Broadwater, Gloria Ren, Xiu-Rong Chen, Wei Castro, Henry Lehmann, Frederic Spector, Neil Wei, Junping Osada, Takuya Lyerly, H Kim Morse, Michael A |
| author_facet | Hamilton, Erika Blackwell, Kimberly Hobeika, Amy C Clay, Timothy M Broadwater, Gloria Ren, Xiu-Rong Chen, Wei Castro, Henry Lehmann, Frederic Spector, Neil Wei, Junping Osada, Takuya Lyerly, H Kim Morse, Michael A |
| author_sort | Hamilton, Erika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3618320 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36183202013-04-07 Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion Hamilton, Erika Blackwell, Kimberly Hobeika, Amy C Clay, Timothy M Broadwater, Gloria Ren, Xiu-Rong Chen, Wei Castro, Henry Lehmann, Frederic Spector, Neil Wei, Junping Osada, Takuya Lyerly, H Kim Morse, Michael A J Transl Med Correction BioMed Central 2013-03-27 /pmc/articles/PMC3618320/ http://dx.doi.org/10.1186/1479-5876-11-82 Text en Copyright © 2013 Hamilton et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correction Hamilton, Erika Blackwell, Kimberly Hobeika, Amy C Clay, Timothy M Broadwater, Gloria Ren, Xiu-Rong Chen, Wei Castro, Henry Lehmann, Frederic Spector, Neil Wei, Junping Osada, Takuya Lyerly, H Kim Morse, Michael A Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title | Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title_full | Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title_fullStr | Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title_full_unstemmed | Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title_short | Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion |
| title_sort | correction: phase 1 clinical trial of her2-specific immunotherapy with concomitant her2 kinase inhibtion |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618320/ http://dx.doi.org/10.1186/1479-5876-11-82 |
| work_keys_str_mv | AT hamiltonerika correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT blackwellkimberly correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT hobeikaamyc correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT claytimothym correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT broadwatergloria correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT renxiurong correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT chenwei correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT castrohenry correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT lehmannfrederic correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT spectorneil correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT weijunping correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT osadatakuya correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT lyerlyhkim correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion AT morsemichaela correctionphase1clinicaltrialofher2specificimmunotherapywithconcomitanther2kinaseinhibtion |